These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26368591)

  • 41. Laboratory tests for the diagnosis of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Fasanella AR; Wood JJ; Bakhos M
    Semin Thromb Hemost; 1999; 25 Suppl 1():43-9. PubMed ID: 10357151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
    Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparin-induced thrombocytopenia.
    Szokol JW
    Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):73-4. PubMed ID: 20472634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
    Alberio L
    Curr Opin Hematol; 2008 Sep; 15(5):456-64. PubMed ID: 18695368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newer insights on the mechanism of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Prechel MM; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():57-67. PubMed ID: 15085467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients.
    Selleng S; Selleng K
    Thromb Haemost; 2016 Oct; 116(5):843-851. PubMed ID: 27411507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin-induced thrombocytopenia.
    Greinacher A; Althaus K; Krauel K; Selleng S
    Hamostaseologie; 2010 Jan; 30(1):17-8, 20-8. PubMed ID: 20162249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
    Mattioli AV
    Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Heparin-induced thrombocytopenia: Update].
    Camoin-Jau L; Mariotti A; Suchon P; Morange PE
    Rev Med Interne; 2022 Jan; 43(1):18-25. PubMed ID: 34535328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.
    Palatianos G; Michalis A; Alivizatos P; Lacoumenda S; Geroulanos S; Karabinis A; Iliopoulou E; Soufla G; Kanthou C; Khoury M; Sfyrakis P; Stavridis G; Astras G; Vassili M; Antzaka C; Marathias K; Kriaras I; Tasouli A; Papadopoulos K; Katafygioti M; Matoula N; Angelidis A; Melissari E
    Am J Hematol; 2015 Jul; 90(7):608-17. PubMed ID: 25808486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin-induced thrombocytopenia.
    Bambrah RK; Pham DC; Zaiden R; Vu H; Tai S
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):594-9. PubMed ID: 22236986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparin-induced thrombocytopenia: an overview.
    Kelton JG
    Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heparin-Induced thrombocytopenia: minimising the risks in the elderly patient.
    Tardy-Poncet B; Tardy B
    Drugs Aging; 2000 May; 16(5):351-64. PubMed ID: 10917073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital.
    Cosmi B; Legnani C; Cini M; Borgese L; Sartori M; Palareti G
    Intern Emerg Med; 2023 Oct; 18(7):1971-1980. PubMed ID: 37568069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunologic Effects of Heparin Associated With Hemodialysis: Focus on Heparin-Induced Thrombocytopenia.
    Warkentin TE
    Semin Nephrol; 2023 Nov; 43(6):151479. PubMed ID: 38195304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin-induced thrombocytopenia.
    Chong BH
    Aust N Z J Med; 1992 Apr; 22(2):145-52. PubMed ID: 1530537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging therapy options in heparin-induced thrombocytopenia.
    Chaudhary RK; Khanal N; Giri S; Pathak R; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2014; 12(1):50-8. PubMed ID: 25374012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.